Previous Article | Next Article ![]()
Mol. Cell. Biol., Jul 1996, 3923-3933, Vol 16, No. 7
R Khosravi-Far, MA White, JK Westwick, PA Solski, M Chrzanowska-Wodnicka, L Van Aelst, MH Wigler and CJ Der
Substantial evidence supports a critical role for the activation of the
Raf-1/MEK/mitogen-activated protein kinase pathway in oncogenic Ras-
mediated transformation. For example, dominant negative mutants of Raf- 1,
MEK, and mitogen-activated protein kinase all inhibit Ras transformation.
Furthermore, the observation that plasma membrane- localized Raf-1 exhibits
the same transforming potency as oncogenic Ras suggests that Raf-1
activation alone is sufficient to mediate full Ras transforming activity.
However, the recent identification of other candidate Ras effectors (e.g.,
RalGDS and phosphatidylinositol-3 kinase) suggests that activation of other
downstream effector-mediated signaling pathways may also mediate Ras
transforming activity. In support of this, two H-Ras effector domain
mutants, H-Ras(12V, 37G) and H-Ras(12V, 40C), which are defective for Raf
binding and activation, induced potent tumorigenic transformation of some
strains of NIH 3T3 fibroblasts. These Raf-binding defective mutants of
H-Ras induced a transformed morphology that was indistinguishable from that
induced by activated members of Rho family proteins. Furthermore, the
transforming activities of both of these mutants were synergistically
enhanced by activated Raf-1 and inhibited by the dominant negative
RhoA(19N) mutant, indicating that Ras may cause transformation that occurs
via coordinate activation of Raf-dependent and -independent pathways that
involves Rho family proteins. Finally, cotransfection of H-Ras(12V, 37G)
and H-Ras(12V, 40C) resulted in synergistic cooperation of their
focus-forming activities, indicating that Ras activates at least two
Raf-independent, Ras effector-mediated signaling events.
Copyright © 1996, American Society for Microbiology
Oncogenic Ras activation of Raf/mitogen-activated protein kinase- independent pathways is sufficient to cause tumorigenic transformation
Department of Pharmacology, University of North Carolina at Chapel Hill, 27599-7365,USA.
This article has been cited by other articles:
B Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras. Science
278: 1812-1815
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»